Hims & Hers stock skyrockets 40% as Novo Nordisk ends feud, agrees to sell Ozempic and Wegovy on platformMarch 9, 2026
Stocks Hims & Hers stock skyrockets 40% as Novo Nordisk ends feud, agrees to sell Ozempic and Wegovy on platformBy AdminMarch 9, 2026 Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk…
